Pulmatrix, Inc. Common Stock

PULM XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

4.8M

Short interest (May 15)

0.9%

Net Short (Jun 03 ): 0.0%

Borrow Fee

4.60%

↓ 2.8%

Available Shares

100K

↑ 30.0%

Price Chart

Company Overview

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001574235

Asset Type: CS

Market Data

Market Cap: $4,821,016

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 4.60%

Range: 4.60% - 4.60%

Available Shares 100K

Range: 100K - 100K

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 33.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime